NCT05000294 2026-02-18Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesUniversity of FloridaPhase 1/2 Suspended29 enrolled
NCT06254911 2026-01-27Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal CarcinomaEmory UniversityPhase 2 Suspended20 enrolled
NCT05620771 2025-10-20Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-riskNorthwestern UniversityPhase 2 Suspended84 enrolled